Cbdmd Inc Stock Price, News & Analysis

cbdMD (NYSE American: YCBD) announced that its Herbal Oasis THC-infused social seltzer is expanding distribution across most of Florida via a new partnership with Bevtalk Distribution.

Bevtalk will target convenience stores, independent retailers, and specialty beverage accounts, with first shipments already begun and broader placements rolling out through the remainder of 2025. Herbal Oasis blends hemp-derived THC, CBG, and adaptogenic mushrooms and is available in flavors including Lemon Lift, Berry Fusion, Tropical Twist, Mango Bliss, and Tropic Wave. The release cites a growing THC beverage category—estimated $1.1B in U.S. sales in 2024 and projected >25% growth in 2025.

cbdMD (NYSE American: YCBD) announced that its Herbal Oasis THC-infused social seltzer is expanding distribution across most of Florida via a new partnership with Bevtalk Distribution.

Bevtalk will target convenience stores, independent retailers, and specialty beverage accounts, with first shipments already begun and broader placements rolling out through the remainder of 2025. Herbal Oasis blends hemp-derived THC, CBG, and adaptogenic mushrooms and is available in flavors including Lemon Lift, Berry Fusion, Tropical Twist, Mango Bliss, and Tropic Wave. The release cites a growing THC beverage category—estimated $1.1B in U.S. sales in 2024 and projected >25% growth in 2025.

cbdMD (NYSE American: YCBD) has secured a $1.7 million private placement through the issuance of Series B Convertible Preferred Stock to institutional investors, including C/M Capital Master Fund, LP. The company will receive net proceeds of $1.5 million for working capital and strategic initiatives.

The preferred shares feature a 10% annual dividend and are convertible to common stock at $1.00 per share. CEO Ronan Kennedy highlighted that the company will end its fiscal year with over $2.2 million in cash, strengthening their balance sheet and supporting efforts to regain full listing compliance while expanding distribution of their consumer brands.

cbdMD (NYSE American: YCBD) has launched Inferno Freeze, its most powerful topical product designed for athletes and fitness enthusiasts. The new product features an advanced full-spectrum formula containing 3000mg CBD, 500mg CBDa, and 50mg THC combined with cooling agents including 4% Menthol, 3% Camphor, and 0.04% Capsaicin.

The product utilizes nano-technology for enhanced absorption and effectiveness, incorporating USA-grown hemp and non-GMO ingredients. This launch expands cbdMD's topicals line and complements their existing portfolio of ingestibles, pet products, functional mushrooms, and hemp-derived beverages.

Herbal Oasis (NYSE:YCBD), a hemp-derived THC-infused social seltzer brand, has announced its expansion into Minnesota through a new partnership with Global Reserve Distribution (GRD). This strategic move marks the company's first expansion beyond its Southeast market base.

The expansion comes as the THC beverage market shows significant growth, with U.S. THC Beverage sales reaching $1.1 billion in 2024 and projected to grow by over 25% in 2025. The market is expected to triple by 2030. Herbal Oasis differentiates itself with beverages infused with THC, CBG, and adaptogenic mushrooms, targeting consumers seeking alternatives to alcohol and traditional cannabis products.

Herbal Oasis (NYSE:YCBD) has announced a strategic distribution partnership with Best Brands to expand its THC-infused seltzer products into Tennessee. This expansion follows successful launches in Alabama, Florida, Georgia, and North Carolina, marking the company's growing presence in the Southeast region.

The partnership comes amid significant growth in the THC beverage market, with Brightfield projecting 50% growth in US Sales to over $571 million in 2025. Herbal Oasis's products, infused with THC, CBG, and functional mushrooms, are positioned as modern alternatives to alcohol for consumers seeking clarity and connection.

cbdMD (NYSE American: YCBD) reported Q3 2025 financial results with revenue of $4.6 million, down 10.9% from $5.2 million in the prior year period. The company's operating loss widened to $905,000 from $382,000 year-over-year, while gross margin decreased from 66% to 61%.

Key developments include the completion of a marketing team overhaul, expansion of Herbal Oasis beverage brand into 7 states, and the conversion of Series A Preferred Stock which eliminated $6.7 million in accrued dividend liability. The company's book value increased to $6.1 million as of June 30, 2025, up from $0.67 million in March 2025.

Direct-to-consumer sales represented 78% of total revenue at $3.6 million, while wholesale revenue contributed 22% at $1.0 million. The company ended the quarter with $1.1 million in cash and working capital of $2.0 million.

cbdMD (NYSE American: YCBD), a leading CBD company, has scheduled a conference call to discuss its Q3 FY2025 financial results for the period ending June 30, 2025. The call will take place on Thursday, August 14, 2025, at 4:20 p.m. Eastern Time.

Investors can access the call through multiple channels including USA/Canada (833-821-3524) and International (647-846-2919) dial-in numbers. A replay will be available with passcode 5327882, and the webcast replay will remain accessible through August 15, 2026, via the provided link.

cbdMD (NYSE American: YCBD) has announced the retail launch of its Herbal Oasis Social Tonics at select Total Wine locations in Charlotte and surrounding North Carolina areas. The hemp-derived THC seltzers, initially launched in late 2024, feature a unique blend of functional mushrooms, adaptogens, and nootropics including Lion's Mane, Reishi, Cordyceps, and Maitake.

The product line offers four flavors - Berry Fusion, Lemon Lift, Mango Bliss, and Tropical Twist - and is positioned as a low-calorie alternative to alcoholic beverages. Each drink is enhanced with L-theanine and B12, designed to provide calm energy and social clarity.